IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human
IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

Immobilized Human IL-15, No Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human, His Tag with the EC50 of 55.8 ng/ml determined by ELISA.

IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

The purity of BIL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human

Interleukin-15 receptor alpha (IL-15R alpha) is a high affinity IL-15 binding protein that is crucial for mediating IL-15 functions such as memory CD8 T cell proliferation and NK, NK/T cell, and intestinal intraepithelial lymphocyte development.
Z04495
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IL-15RA/IL-15 R alpha/CD215 (Ile31-Thr205)
Accession # Q13261-1		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized Human IL­15 at 2μg/ml (100μl/Well) on the plate can bind IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 21.3 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human
    • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

    Immobilized Human IL-15, No Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human, His Tag with the EC50 of 55.8 ng/ml determined by ELISA.

  • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human
    • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

    The purity of BIL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human
    • IL-15RA/IL-15 R Alpha/CD215[Biotin], His & Avi, Human

    IL-15RA/IL-15 R alpha/CD215[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Interleukin-15 receptor alpha (IL-15R alpha) is a high affinity IL-15 binding protein that is crucial for mediating IL-15 functions such as memory CD8 T cell proliferation and NK, NK/T cell, and intestinal intraepithelial lymphocyte development.
Synonyms IL-15 R alpha; CD215; IL-15RA; MGC104179

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.